Commonwealth legislation

National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 79 of 2008)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

7/10 complexity

This Determination sets the conditions for supplying and paying for pharmaceutical benefits under the National Health Act. It defines key terms, fixes how payment is calculated (different rules when a brand is named or not), requires whole-pack supply for listed items, and lists drugs and preparation types (including dangerous drugs and standard extemporaneous formulas).

It affects approved pharmacists, approved medical practitioners, prescribers and Medicare Australia: prescribing and supply choices determine how much the Commonwealth pays and what pharmacists receive, and certain written elections and notices to the CEO of Medicare Australia are required.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 79 of 2008).

Source text: opening excerpt

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 79 of 2008)

Determination — Conditions (PB 79 of 2008)

as amended

made under paragraph 98C(1)(b) of the

National Health Act 1953

This compilation was prepared on 30 November 2008
taking into account amendments up to PB 111 of 2008

Prepared by the Office of Legislative Drafting and Publishing,
Attorney‑General’s Department, Canberra

Determination – conditions (PB 79 of 2008)

Commencement

This instrument commences on 1 August 2008.

Repeal

Instrument number PB 52 of 2007 is repealed.

Definitions

“Act” means the National Health Act 1953;

“approved price to pharmacists” has the same meaning as in subsection 98B(3) of the Act;

“Commonwealth price” has the same meaning as in subsection 84(1) of the Act;

“extemporaneously-prepared pharmaceutical benefit” means a pharmaceutical benefit other than a ready-prepared pharmaceutical benefit;

“prescription” includes a prescription written on an authority prescription made under regulation 13 of the Regulations, a prescription required to be submitted to the Chief Executive Officer of Medicare Australia for the purposes of a determination made under subsection 85(2A) or subsection 85A(2) of the Act, a repeat authorisation, or a deferred supply authorisation;

“ready-prepared pharmaceutical benefit” means a listed brand of a pharmaceutical item;

“Regulations” means the National Health (Pharmaceutical Benefits) Regulations 1960 made under the Act;

“standard formula preparation” means an extemporaneously-prepared pharmaceutical benefit that is listed in Schedule 5 to this Determination.

Schedules

For the supply of pharmaceutical benefits:

(a) pharmaceutical benefits that involve the admixture of ready-prepared ingredients are set out in Schedule 1;

(b) drugs that are used in the preparation of extemporaneously-prepared pharmaceutical benefits and that are unstable or packed sterile and unused quantities of which are unsuitable for future use are set out in Schedule 2 ;

(c) pharmaceutical benefits that are classified as dangerous drugs for the purpose of payment of a dangerous drug fee are pharmaceutical benefits that have the pharmaceutical items which have the listed drug in the form set out in Schedule 3 to this Determination;

<table cellspacing="0" cellpadding="0" style="width:453.6pt; margin-right:auto; margin-left:auto; margin-bottom:0pt; border-collapse:collapse"><thead><tr><td colspan="2" style="width:442.8pt; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">SCHEDULE 1 – PHARMACEUTICAL BENEFITS THAT INVOLVE THE ADMIXTURE OF READY PREPARED INGREDIENTS</td></tr><tr><td style="width:147.95pt; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:bottom">Listed Drug</td><td style="width:284.05pt; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:bottom">Form (strength, type, size, etc.)</td></tr></thead><tbody><tr><td style="width:147.95pt; border-top:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Amoxycillin with Water – Purified BP</td><td style="width:284.05pt; border-top:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"></td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"></td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"></td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Amoxycillin with Clavulanic Acid and Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mLPowder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Azithromycin with Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Cefaclor with Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mLPowder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Cephalexin with Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Granules for oral suspension 125 mg per 5 mL, 100 mLGranules for oral suspension 250 mg per 5 mL, 100 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Clarithromycin with Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral liquid 250 mg per 5 mL, 50 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Erythromycin with Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mLPowder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL</td></tr><tr><td style="width:147.95pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Flucloxacillin with Water – Purified BP</td><td style="width:284.05pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mLPowder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL</td></tr><tr><td style="width:147.95pt; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Mycophenolic Acid with Water – Purified BP</td><td style="width:284.05pt; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top">Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL</td></tr></tbody></table>